Gene therapy: Microdystrophin restores muscle strength in Duchenne muscular dystrophy

Researchers have demonstrated the efficacy of an innovative gene therapy in the treatment of Duchenne muscular dystrophy. After injecting microdystrophin (a 'shortened' version of the dystrophin gene) via a drug vector, the researchers managed to restore muscle strength and stabilise the clinical symptoms in dogs naturally affected by Duchenne muscular dystrophy.